In PAH, Kynurenine Levels Predict Severity, Treatment Response - Pulmonary Hypertension News

8/8/2022 12:00:00 AM2 years 8 months ago
by Steve Bryson, PhD, Steve Bryson, PhD
by Steve Bryson, PhD, Steve Bryson, PhD
Elevated metabolites of the kynurenine pathway found in PAH patients were predictors of disease severity, response to therapy, and survival.
Elevated metabolites of the kynurenine pathway in the bloodstream of people with pulmonary arterial hypertension (PAH) when they’re diagnosed predicted disease severity, their response to therapy, an… [+5590 chars]
full article...